Press-release for stocks related to approval

tags : Approval source : Www.fda.gov

save search

FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals
Published: 2021-09-02 (Crawled : 15:15) - fda.gov
FNCTF | News | $11.16 -20.84% 130

Communications

| Email alert Add to watchlist
fda therapy drug approval fda ide milestone

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-27 (Crawled : 14:58) - fda.gov
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 200.7% | O: 0.21% H: 0.14% C: -0.05%
BMY | $48.99 -0.31% 0.0% 9.1M

Health Technology

| -27.4% | O: -0.64% H: 0.68% C: 0.34%
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| -77.76% | O: -0.05% H: 1.0% C: -2.76%
YMAB | $15.37 1.39% 1.37% 510K

Health Technology

| -53.68% | O: -0.67% H: 2.09% C: -0.18%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -10.37% | O: -0.54% H: 0.65% C: 0.49%
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| 55.8% | O: -1.6% H: 2.25% C: 2.2%
KPTI | $1.085 -3.98% -4.15% 1.6M

Health Technology

| -86.78% | O: -0.47% H: 1.53% C: -0.35%
INCY | $51.62 -0.58% -0.58% 2.5M

Health Technology

| -32.84% | O: -0.41% H: 0.14% C: -0.84%
EPZM | $1.47 -1.34% 0.0%

Health Technology

| -77.83% | O: 2.34% H: 0.37% C: -1.69%
CLVS | $0.0812 -3.94%

Health Technology

| -98.19% | O: -0.21% H: 4.42% C: 2.74%
BPMC | $92.32 1.89% 1.85% 780K

Health Technology

| 10.59% | O: -0.12% H: 0.58% C: -0.16%
AVEO | $15.0 0.0% 0

Health Technology

| 191.17% | O: -1.17% H: 2.55% C: 0.59%
cancer approval

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-22 (Crawled : 11:36) - fda.gov
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 208.2% | O: -0.0% H: 1.02% C: 0.51%
BMY | $48.99 -0.31% 0.0% 9.1M

Health Technology

| -26.83% | O: -0.03% H: 1.28% C: 1.22%
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| -79.21% | O: 0.18% H: 0.31% C: -2.26%
YMAB | $15.37 1.39% 1.37% 510K

Health Technology

| -56.75% | O: -1.57% H: 3.71% C: 0.43%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -10.15% | O: 0.45% H: 0.12% C: -0.6%
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| 54.21% | O: -0.36% H: 1.56% C: 0.9%
KPTI | $1.085 -3.98% -4.15% 1.6M

Health Technology

| -87.93% | O: -0.53% H: 0.38% C: -3.01%
INCY | $51.62 -0.58% -0.58% 2.5M

Health Technology

| -34.39% | O: -0.39% H: 0.11% C: -0.27%
EPZM | $1.47 -1.34% 0.0%

Health Technology

| -80.03% | O: -1.49% H: 2.0% C: -2.34%
CLVS | $0.0812 -3.94%

Health Technology

| -98.35% | O: 0.0% H: 0.58% C: -3.46%
BPMC | $92.32 1.89% 1.85% 780K

Health Technology

| 5.85% | O: -0.84% H: 1.72% C: 0.61%
AVEO | $15.0 0.0% 0

Health Technology

| 176.66% | O: 2.21% H: 0.0% C: -4.87%
cancer approval

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-16 (Crawled : 19:11) - fda.gov
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| Email alert Add to watchlist
INCY | $51.62 -0.58% -0.58% 2.5M

Health Technology

| Email alert Add to watchlist
CLVS | $0.0812 -3.94%

Health Technology

| Email alert Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| Email alert Add to watchlist
KPTI | $1.085 -3.98% -4.15% 1.6M

Health Technology

| Email alert Add to watchlist
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| Email alert Add to watchlist
YMAB | $15.37 1.39% 1.37% 510K

Health Technology

| Email alert Add to watchlist
BPMC | $92.32 1.89% 1.85% 780K

Health Technology

| Email alert Add to watchlist
EPZM | $1.47 -1.34% 0.0%

Health Technology

| Email alert Add to watchlist
BMY | $48.99 -0.31% 0.0% 9.1M

Health Technology

| Email alert Add to watchlist
AVEO | $15.0 0.0% 0

Health Technology

| Email alert Add to watchlist
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| Email alert Add to watchlist
cancer approval

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-12 (Crawled : 00:01) - fda.gov
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 207.94% | O: -0.98% H: 1.2% C: 0.36%
BMY | $48.99 -0.31% 0.0% 9.1M

Health Technology

| -26.83% | O: -0.15% H: 1.19% C: 0.66%
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| -80.87% | O: -0.41% H: 2.22% C: -1.07%
YMAB | $15.37 1.39% 1.37% 510K

Health Technology

| -53.98% | O: 0.03% H: 1.08% C: -0.36%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -10.46% | O: 1.84% H: 0.27% C: -0.38%
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| 55.09% | O: -0.08% H: 1.11% C: -1.02%
KPTI | $1.085 -3.98% -4.15% 1.6M

Health Technology

| -88.77% | O: 0.1% H: 1.48% C: -3.38%
INCY | $51.62 -0.58% -0.58% 2.5M

Health Technology

| -36.71% | O: 0.0% H: 0.49% C: -1.05%
EPZM | $1.47 -1.34% 0.0%

Health Technology

| -80.98% | O: -0.26% H: 1.09% C: -0.52%
CLVS | $0.0812 -3.94%

Health Technology

| -98.41% | O: 5.35% H: 0.7% C: -7.18%
BPMC | $92.32 1.89% 1.85% 780K

Health Technology

| 5.4% | O: -0.21% H: 0.05% C: -2.51%
AVEO | $15.0 0.0% 0

Health Technology

| 144.62% | O: 1.47% H: 0.0% C: -5.79%
cancer approval

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-09 (Crawled : 18:17) - fda.gov
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| Email alert Add to watchlist
INCY | $51.62 -0.58% -0.58% 2.5M

Health Technology

| Email alert Add to watchlist
CLVS | $0.0812 -3.94%

Health Technology

| Email alert Add to watchlist
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| Email alert Add to watchlist
KPTI | $1.085 -3.98% -4.15% 1.6M

Health Technology

| Email alert Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| Email alert Add to watchlist
BMY | $48.99 -0.31% 0.0% 9.1M

Health Technology

| Email alert Add to watchlist
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| Email alert Add to watchlist
YMAB | $15.37 1.39% 1.37% 510K

Health Technology

| Email alert Add to watchlist
BPMC | $92.32 1.89% 1.85% 780K

Health Technology

| Email alert Add to watchlist
EPZM | $1.47 -1.34% 0.0%

Health Technology

| Email alert Add to watchlist
AVEO | $15.0 0.0% 0

Health Technology

| Email alert Add to watchlist
cancer approval

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-01 (Crawled : 13:13) - fda.gov
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 218.63% | O: -0.0% H: 0.87% C: 0.71%
BMY | $48.99 -0.31% 0.0% 9.1M

Health Technology

| -26.46% | O: -0.6% H: 0.48% C: 0.21%
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| -80.78% | O: -0.45% H: 2.35% C: 1.86%
YMAB | $15.37 1.39% 1.37% 510K

Health Technology

| -55.15% | O: 0.24% H: 3.9% C: 3.69%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -12.12% | O: -0.27% H: 0.36% C: 0.08%
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| 61.16% | O: -0.35% H: 3.65% C: 3.24%
KPTI | $1.085 -3.98% -4.15% 1.6M

Health Technology

| -89.05% | O: 0.0% H: 3.0% C: 3.0%
INCY | $51.62 -0.58% -0.58% 2.5M

Health Technology

| -38.29% | O: -0.05% H: 0.49% C: -0.08%
EPZM | $1.47 -1.34% 0.0%

Health Technology

| -82.31% | O: 0.84% H: 1.67% C: 0.95%
CLVS | $0.0812 -3.94%

Health Technology

| -98.52% | O: 0.0% H: 1.9% C: 0.0%
BPMC | $92.32 1.89% 1.85% 780K

Health Technology

| 3.01% | O: 0.0% H: 0.67% C: -0.34%
AVEO | $15.0 0.0% 0

Health Technology

| 127.54% | O: 1.21% H: 0.0% C: -5.55%
cancer approval

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-06-16 (Crawled : 19:52) - fda.gov
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 231.28% | O: -0.22% H: 1.28% C: 0.88%
BMY | $48.99 -0.31% 0.0% 9.1M

Health Technology

| -26.57% | O: 0.16% H: 0.21% C: -0.39%
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| -79.66% | O: 0.0% H: 1.87% C: -0.04%
YMAB | $15.37 1.39% 1.37% 510K

Health Technology

| -57.63% | O: 0.0% H: 5.48% C: 5.2%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -13.38% | O: -0.98% H: 0.77% C: 0.65%
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| 71.92% | O: 0.08% H: 2.77% C: 2.29%
KPTI | $1.085 -3.98% -4.15% 1.6M

Health Technology

| -88.73% | O: -0.8% H: 6.08% C: 5.53%
INCY | $51.62 -0.58% -0.58% 2.5M

Health Technology

| -37.54% | O: -0.29% H: 0.84% C: 0.3%
EPZM | $1.47 -1.34% 0.0%

Health Technology

| -83.35% | O: -0.45% H: 1.02% C: 0.23%
CLVS | $0.0812 -3.94%

Health Technology

| -98.54% | O: 1.35% H: 5.34% C: 1.67%
BPMC | $92.32 1.89% 1.85% 780K

Health Technology

| 5.9% | O: -0.81% H: 3.66% C: -1.58%
AVEO | $15.0 0.0% 0

Health Technology

| 119.55% | O: -0.29% H: 1.76% C: -2.5%
cancer approval

FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
Published: 2021-06-11 (Crawled : 18:03) - fda.gov
CLVS | $0.0812 -3.94%

Health Technology

| -98.56% | O: 0.5% H: 0.33% C: -3.67%
approval fda granted cancer prostate cancer grant

FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumor expression ≥1%)
Published: 2021-06-11 (Crawled : 18:03) - fda.gov
A | $139.2 3.95% -0.14% 2M

Health Technology

| -6.4% | O: 0.21% H: 0.17% C: 0.12%
approval fda fda approval nivolumab

FDA approves ramucirumab plus erlotinib for first-line metastatic NSCLC
Published: 2021-06-11 (Crawled : 17:07) - fda.gov
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 213.15% | O: -2.79% H: 1.13% C: -1.29%
fda approval fda approval

FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukemia
Published: 2021-06-11 (Crawled : 14:04) - fda.gov
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 44.43% | O: 0.0% H: 0.1% C: -0.71%
fda granted approval leukemia myeloid leukemia grant acute myeloid leukemia

FDA approves selinexor for refractory or relapsed multiple myeloma
Published: 2021-06-11 (Crawled : 13:47) - fda.gov
KPTI | $1.085 -3.98% -4.15% 1.6M

Health Technology

| -89.29% | O: 1.61% H: 0.09% C: -3.73%
fda approval fda approval

FDA approves pralsetinib for RET-altered thyroid cancers
Published: 2021-06-11 (Crawled : 13:47) - fda.gov
BPMC | $92.32 1.89% 1.85% 780K

Health Technology

| 7.73% | O: 1.41% H: 2.24% C: 1.88%
cancer fda approval fda approval

FDA grants accelerated approval to naxitamab for high-risk neuroblastoma in bone or bone marrow
Published: 2021-06-11 (Crawled : 13:47) - fda.gov
YMAB | $15.37 1.39% 1.37% 510K

Health Technology

| -59.61% | O: 0.05% H: 1.54% C: -3.36%
risk fda granted approval grant

FDA approves isatuximab-irfc for multiple myeloma
Published: 2021-06-11 (Crawled : 12:53) - fda.gov
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -13.96% | O: 0.13% H: 0.11% C: -0.09%
fda approval fda approval

FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma
Published: 2021-06-11 (Crawled : 12:43) - fda.gov
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| -78.94% | O: -0.18% H: 2.19% C: 0.14%
fda granted approval grant t-cell

FDA approves nivolumab for resected esophageal or GEJ cancer
Published: 2021-06-11 (Crawled : 12:24) - fda.gov
BMY | $48.99 -0.31% 0.0% 9.1M

Health Technology

| -27.08% | O: 0.74% H: 0.07% C: -0.81%
cancer fda approval fda approval nivolumab

FDA grants accelerated approval to amivantamab-vmjw for metastatic non-small cell lung cancer
Published: 2021-06-10 (Crawled : 10:52) - fda.gov
GH | News M | $17.34 -1.42% -1.44% 1.8M

Health Services

| -84.6% | O: -0.54% H: 7.61% C: 6.07%
cancer fda granted approval grant

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-06-09 (Crawled : 19:32) - fda.gov
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology